With an estimated CAGR of 12.8% during the projected period, the antibody therapy market share is expected to reach US$ 700 Billion by 2032, from US$ 186 Bn in a report published by FMI. The study finds that the rising demand for Humira proportionately reflects on the adoption of antibody therapy. COVID-19 has caused the world to come to …
Continue reading “Antibody Therapy Market worth US$ 727.78 Bn by 2032 | Exclusive Report by FMI”